Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Leukemia × Idarubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 2 Leukemia 1

Interventions

blinatumomab 3 Cytarabine 3 venetoclax 2 revumenib 2 Daunorubicin 2 quizartinib 1 obinutuzumab 1 nilotinib 1 ivosidenib 1 etoposide phosphate 1 bosutinib 1 acalabrutinib 1 Mitoxantrone 1 Midazolam 1 Itraconazole 1 Imatinib Mesylate 1 Idarubicin 1 Gemtuzumab 1 Etoposide 1 Drug Therapy 1 Cobicistat 1 Azacitidine 1 Asparaginase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02668653 2024-08-06

QuANTUM-First

Daiichi Sankyo

Phase 3 Completed

539 enrolled 20 charts 1 FDA

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡